El-Assal et al developed a score for predicting recurrence of a hepatocellular carcinoma following curative resection. These can help to identify a patient who may benefit from more aggressive management. The authors are Shimane Medical University in Izumo, Japan.
A curative resection was defined as removal of all grossly evident tumor at the time of surgery, with no evidence of tumor at 3 and 6 weeks after surgery on imaging studies.
Parameters:
(1) invasion of the portal vein
(2) invasion of the hepatic vein
(3) invasion of the serosa
(4) intrahepatic metastases
(5) tumor capsule and invasion of tumor capsule (if capsule present)
|
Parameter |
Finding |
Points |
|
invasion of portal vein |
absent |
0 |
|
|
present |
3 |
|
invasion of hepatic vein |
absent |
0 |
|
|
present |
1 |
|
invasion of serosa |
absent |
0 |
|
|
present |
1 |
|
intrahepatic metastasis |
absent |
0 |
|
|
present |
3 |
|
tumor capsule |
none |
1 |
|
|
present, not invaded by tumor |
0 |
|
|
present, invasded by tumor |
3 |
total score =
= SUM(points for all 5 parameters)
Interpretation:
• minimum score: 0
• maximum score: 11
• The higher the score the more likely the tumor will recur and the shorter the survival.
|
Total Score |
Invasiveness |
8 Year Disease Free Survival |
|
0 or 1 |
low |
54% |
|
2 to 4 |
moderate |
10% |
|
5 to 11 |
high |
0% |
Specialty: Hematology Oncology, Surgery, general, Gastroenterology
ICD-10: ,
